发明名称 PROTEIN AND LIPID BIOMARKERS PROVIDING CONSISTENT IMPROVEMENT TO THE PREDICTION OF TYPE 2 DIABETES
摘要 The invention relates to biomarkers associated with Diabetes, including protein and lipid metabolite biomarkers, methods of using the biomarkers to determine the risk that an individual will develop Diabetes, and methods of screening a population to identify persons at risk for developing Diabetes and other pre-diabetic conditions.
申请公布号 US2017003297(A1) 申请公布日期 2017.01.05
申请号 US201514945200 申请日期 2015.11.18
申请人 True Health Diagnostics, LLC 发明人 McKenna Michael P.;Watkins Steve M.
分类号 G01N33/68;G01N33/66;G06F19/00;G01N33/92 主分类号 G01N33/68
代理机构 代理人
主权项 1: A method of evaluating risk for developing a diabetic condition, the method comprising: (a) obtaining biomarker measurement data for an individual, wherein the biomarker measurement data is representative of measurements of biomarkers in at least one biological sample from the individual; wherein said biomarkers comprise: (i) glucose, (ii) at least three protein biomarkers selected from the protein biomarkers in Table 1 and (iii) at least one lipid metabolite selected from the lipid metabolites in Table 2; and (b) evaluating risk for the individual developing a diabetic condition based on an output from a model, wherein the model is executed based on an input of the biomarker measurement data.
地址 Frisco TX US